CXCL13 CSF level inversely correlates with duration of disease in primary progressive multiple sclerosis
Journal of Medical Science · 2016
DOI: 10.20883/169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Science, 2016. Verfasst von Jacek Losy und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Chemokines are important factors in the immunopathogenesis of multiple sclerosis. The objective of the study was to examine the CSF and serum levels of CXCL13 and CCL5 chemokines in primary progressive MS, compare results with relapsing remitting MS and control group with other noninflammatory neurological disorders. The levels of chemokines was measured by ELISA method. The CXCL13 CSF levels in PP and RR MS were higher in comparison with control group, without significant differences between these podgroups. Additionally CXCL13 level in PP MS inversely correlated with duration of the disease. CCL5 CSF level was also significantly higher in PP MS in comparison with control group. The results demonstrate involvement of CXCL13 and CCL5 chemokines in the immunopathogenetic mechanisms of primary progressive MS.
Zitieren
APA
Losy, J., Iwanowski, P., Kaufman, E., & Wójcicka, M. (2016). CXCL13 CSF level inversely correlates with duration of disease in primary progressive multiple sclerosis. Journal of Medical Science. https://doi.org/10.20883/169
Vancouver
Losy J, Iwanowski P, Kaufman E, Wójcicka M. CXCL13 CSF level inversely correlates with duration of disease in primary progressive multiple sclerosis. Journal of Medical Science. 2016. doi:10.20883/169
BibTeX
@article{Losy2016,
author = {Losy, Jacek and Iwanowski, Piotr and Kaufman, Elżbieta and Wójcicka, Marlena},
title = {CXCL13 CSF level inversely correlates with duration of disease in primary progressive multiple sclerosis},
journal = {Journal of Medical Science},
year = {2016},
doi = {10.20883/169}
}
EUVIMED